LSB (ysbiopharm.com) Wutah bathi resik saben saham ing taun iki

LSB (LakeShore Biopharma Co.) - tandha merek perusahaan

Developing vaccines against infections involves a fierce struggle for government contracts with global behemoths. The annual EPS growth trajectory visualizes these challenges, with the metric reaching 0.00. LakeShore Biopharma (LSB) is currently cutting costs and restructuring debt, anticipating that transitioning to mass supplies in Asia will lower unit costs and exponentially increase business margins.

YS Biopharma (LSB) - Wutah bathi ing taun lumaku saka 29.05.2024 nganti 04.10.2025

Rincian analitis lan laporan data perusahaan LakeShore Biopharma Co. (LSB)

- nilai saham lan prakiraan konsensus rega:
Rega bursa LakeShore Biopharma Co., Ltd.|LSB - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Biji pasar LSB|LSB - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- rincian nilai buku perusahaan:
Rega Buku Saham LakeShore Biopharma|LSB - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku ysbiopharm.com|LSB - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Utang marang Modal LakeShore Biopharma Co.|LSB - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal ysbiopharm.com|LSB - Utang perusahaan|Utang-utang marang aset resik LSB|LSB - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan LakeShore Biopharma|Rasio cepet ysbiopharm.com
- indikator bathi lan kelipatan valuasi:
LSB - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep LakeShore Biopharma Co.|LSB - Pangali P/E|Rasio prakiraan rega marang bathi YS Biopharma Co., Ltd.|LSB - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan LSB|LSB - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku LakeShore Biopharma|LSB - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan ysbiopharm.com|LSB - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep LakeShore Biopharma Co.
- informasi babagan volume dodolan lan pendapatan:
LSB - Pendapatan lan volume dodolan
Analisis dhasar perusahaan:LSB - LakeShore Biopharma Co., Ltd.
Produk mawa merek LakeShore Biopharma Co., Ltd.

The indicator is calculated as the percentage ratio of current earnings per share to the value of the same period last year. This metric determines the growth rate of real shareholder income and the business's ability to outperform competitors. The stable operation of LakeShore Biopharma Co. (LSB) contract manufacturing plants for vaccine production ensures predictable cash flows. An analysis of annual EPS growth allows for an assessment of production capacity utilization efficiency. The upward trajectory of annual EPS growth confirms the fundamental strength of LakeShore Biopharma Co. (LSB), although it necessitates monitoring the entry price.

Pesaing utama

Kacepetan wutah bathi saben saham ing taun lumaku Summit Therapeutics plc (SMMT)|MRNA (Moderna Corp) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki SutroVax (PCVX)|Wutah bathi resik saben saham ing taun iki TARS (Tarsus Pharmaceuticals)|Wutah bathi resik saben siji saham kanggo taun lumaku CRMD|Wutah bathi ing taun lumaku MCRB (Seres Therapeutics, Inc.)|Prakiraan wutah bathi resik saben saham ing taun iki Spero Therapeutics Inc (SPRO)|SCYX - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku AN2 Therapeutics, Inc.|polypid.com (PYPD) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun iki ITRM|Wutah bathi saben saham ing taun lumaku BiomX Inc|BioPharma Bio (SNGX) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku 60 Degrees Pharmaceuticals (SXTP)|Wutah bathi saben saham ing taun lumaku OGEN (oragenics.com)|Wutah bathi ing taun lumaku OPGN (OpGen, Inc.)